Cargando…
Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
BACKGROUND: Nano-sized drug delivery system has been widely studied as a potential technique to promote tumor-specific delivery of anticancer drugs due to its passive targeting property, but resulting in very restricted improvements in its systemic administration so far. There is a requirement for a...
Autores principales: | Kim, Jeongrae, Song, Sunejeong, Gwak, Minjun, Cho, Hanhee, Yun, Wan Su, Hwang, Namcheol, Kim, Jinseong, Lee, Jun Seo, Kim, Dong-Hwee, Kim, Hyuncheol, Jeon, Seong Ik, Kim, Tae-il, Kim, Kwangmeyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577945/ https://www.ncbi.nlm.nih.gov/pubmed/37845762 http://dx.doi.org/10.1186/s40824-023-00440-4 |
Ejemplares similares
-
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
por: Yun, Wan Su, et al.
Publicado: (2023) -
Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation
por: Cho, Hanhee, et al.
Publicado: (2022) -
Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors
por: Kim, Jinseong, et al.
Publicado: (2023) -
Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
por: Kim, Jeongrae, et al.
Publicado: (2022) -
Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy
por: Kim, Jeongrae, et al.
Publicado: (2022)